Stock 2126 JW (CAYMAN) THERAPEUTICS CO. LTD
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart JW (Cayman) Therapeutics Co. Ltd

Equities

2126

KYG5210T1040

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:07 2024-07-05 am EDT 		5-day change 1st Jan Change
1.94 HKD +2.11% Intraday chart for JW (Cayman) Therapeutics Co. Ltd -1.02% -14.16%
May. 30 JW (Cayman) Therapeutics Presents Trial Data from SLE Drug at Rheumatology Congress MT
May. 30 JW Therapeutics Co. Ltd Announces Research and Development Update Preliminary Clinical Data on Relma-Cel Injection in Adults with Active Systemic Lupus Erythematosus in China At the EURAL 2024 Congress CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
JW (CAYMAN) THERAPEUTICS CO. LTD Stock JW (Cayman) Therapeutics Co. Ltd
 100M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 122B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 112B
ARGENX SE Stock argenx SE
 25.91B -
BIONTECH SE Stock BioNTech SE
 19.33B -
GENMAB A/S Stock Genmab A/S
 16.17B
  1. Stock Market
  2. Equities
  3. 2126 Stock
  4. Charts JW (Cayman) Therapeutics Co. Ltd
  5. Sector Chart